Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic
  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

GCAC Announces Exclusive NFT Artwork Airdrop



Every GCAC Token Holder to Receive Their Own Unique NFT in a World’s First

 

Vancouver, British Columbia, Canada – TheNewswire -August 17, 2021 – Global Cannabis Applications Corp. ("GCAC" or the "Company") (CSE:APP) (CNSX:APP.CN) (FSE:2FA) (OTC:FUAPF), a blockchain pioneer and leading medical cannabis chain-of-custody compliance and data platform, announced today that it will Airdrop a unique non-fungible token “NFT” [1] to everyone that holds GCAC tokens on the record date of August 31st, 2021, at 9am Eastern Time.

 

NFTs are currently taking the blockchain world by storm with sales of over $3.8 billion [2]. The most popular NFT digital media types are images, ranging from amazing photographs to artificial intelligence-generated art. GCAC’s upcoming NFT media giveaway, the “Airdrop”, will feature a unique artwork, per token holder, encompassing the worlds of cannabis and blockchain truths. This Airdrop will be a one of a kind, and exclusive to GCAC token holders.

 

Brad Moore, CEO stated “We are blockchain – and want to showcase how our blockchain not only maintains the truth of our cannabis products, but it also allows Efixii users, and our SaaS grower community, to join the NFT revolution. Using the Efixii Ethereum blockchain, users can publish creative works for the whole world to see. And, just like the awesome artwork in this one-off NFT airdrop for GCAC token holders, the Efixii blockchain community can offer their art for sale on the biggest NFT marketplaces in the world like OpenSea, Rarible or Mintable.” [4]

 

The GCAC marketing token was launched by Company on Ethereum on April 20th [3] and has already gathered over 300 holders [5]. The token entitles the holder to a pro rata share in the quarterly revenues of the Company and has been a great talking point amongst the ever-growing GCAC community on Telegram [6]. GCAC tokens can still be purchased by anyone with an Ethereum or Binance Smart Chain blockchain wallet on either Uniswap or Pancakeswap, resp.  

 

On the record date, each GCAC token holder will automatically be assigned their unique NFT artwork on the Efixii blockchain and will immediately be able to export it to any public NFT marketplace [4] should they wish to sell their NFT to others. The artwork is transferred to GCAC holders with full commercial copyright and without any future-sale royalty payments back to the creator. It really is gifted, in full, to the loyal GCAC community of token holders.

 

[1] https://coinmarketcap.com/alexandria/glossary/non-fungible-token  

[2] https://coinmarketcap.com/nft/collections/ [as of 16 August 2021, 8am ET]

[3] https://cannappscorp.com/uniswap/

[4] https://opensea.io/       https://rarible.com/     https://mintable.app/

[5] https://v2.info.uniswap.org/pair/0xf22645743415d8C06D78C8A4F0eA214041b4544F  

      https://pancakeswap.info/token/0x3a3ee21157906a17ee9775d37e7a8cb3d7df86d6

[6] https://t.me/GCACToken

 

#nft #airdrop #crypto #ethereum #defi #erc721 #uniswap #binance #opensea

 

About Global Cannabis Applications Corp. “GCAC”

GCAC is a global leader in designing, developing, SaaS licensing and acquiring innovative data technologies for the medical cannabis industry. The Citizen Green and Efixii platforms are the world's first end-to-end - from patient to regulator - medical cannabis data solutions. They use six core technologies: mobile applications, artificial intelligence, RegTech, smart databases, Ethereum blockchain and GCAC smart rewards. These technologies transparently disclose cannabis chain-of-custody events, thereby enabling patients to provide crowd-sourced medical cannabis efficacy data. Driven by digital and cannabis industry experts, GCAC is focused on generating revenue from SaaS licensing its technology and acquiring high quality cannabis datasets that improve patient outcomes and to become the world’s largest cannabis efficacy data provider.

For more Company information, please visit www.cannappscorp.com, or review its profiles on www.sedar.com and on the Canadian Securities Exchange's website www.thecse.com.

 

Press Contact

 Phone: +1 (800) 409-5679

 Email: info@cannappscorp.com

Forward-Looking Information 

This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

 

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.

Copyright (c) 2021 TheNewswire - All rights reserved.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.